3.2. Efficacy outcomes
The efficacy results are presented in Figure Percentage changes in lipid profile at 8-wk follow-up. A10 = atorvastatin 10 mg, A5 = atorvastatin 5 mg, A5E = atorvastatin 5 mg and ezetimibe 10 mg, E = ezetimibe 10 mg, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein cholesterol, NS = not significant (Figure Achievement of target low-density lipoprotein cholesterol goal according to the cardiovascular risk category at 8-wk follow-up. A10 = atorvastatin 10 mg, A5 = atorvastatin 5 mg, A5E = atorvastatin 5 mg and ezetimibe 10 mg, E = ezetimibe 10 mg, NS = not significant (